[HTML][HTML] US medical eligibility criteria for contraceptive use, 2024
AT Nguyen - MMWR. Recommendations and Reports, 2024 - cdc.gov
Summary The 2024 US Medical Eligibility Criteria for Contraceptive Use (US MEC)
comprises recommendations for the use of specific contraceptive methods by persons who …
comprises recommendations for the use of specific contraceptive methods by persons who …
Artificial intelligence meets the world experts; updates and novel therapies in autoimmunity-The 14th international congress on autoimmunity 2024 (AUTO14) …
The bi-annual international congress on autoimmunity is a huge opportunity for the medical
community to discuss the latest updates in the field. During the 14th congress 2024 …
community to discuss the latest updates in the field. During the 14th congress 2024 …
Biological markers of high risk of thrombotic recurrence in patients with antiphospholipid syndrome: a literature review
M Lambert, A Brodovitch, JL Mège, D Bertin… - Autoimmunity …, 2024 - Elsevier
Objectives This review aims to identify biological markers of the risk of recurrence of
thrombotic and/or obstetric events in patients with antiphospholipid syndrome (APS) …
thrombotic and/or obstetric events in patients with antiphospholipid syndrome (APS) …
Neutrophil glucose flux as a therapeutic target in antiphospholipid syndrome
Neutrophil hyperactivity and neutrophil extracellular trap release (NETosis) appear to play
important roles in the pathogenesis of the thromboinflammatory autoimmune disease known …
important roles in the pathogenesis of the thromboinflammatory autoimmune disease known …
[PDF][PDF] Guidelines on the investigation and management of antiphospholipid syndrome
DJ Arachchillage, S Platton, K Hickey, J Chu… - Br J …, 2024 - cancer-networks.com
Review of the guideline followed the standard BSH guidelines procedure. Following review
of the draft guideline by the BSH Haemostasis and Thrombosis Task Force and the BSH …
of the draft guideline by the BSH Haemostasis and Thrombosis Task Force and the BSH …
A diagnostic performance study of the 2023 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for patients …
Q Lu, Y Gan, Z Yao, C Li - Arthritis & Rheumatology, 2024 - Wiley Online Library
The 2023 American College of Rheumatology (ACR)/European Alliance of Associations for
Rheumatology (EULAR) antiphospholipid syndrome (APS) classification criteria incorporate …
Rheumatology (EULAR) antiphospholipid syndrome (APS) classification criteria incorporate …
[HTML][HTML] Deciphering the clinical significance of longitudinal antiphospholipid antibody titers
CB Chighizola, R Willis, G Maioli, S Sciascia… - Autoimmunity …, 2024 - Elsevier
In antiphospholipid syndrome (APS), the risk of clinical manifestations increases with higher
titers of antiphospholipid antibodies (aPL). Despite the adoption of aPL titers in the …
titers of antiphospholipid antibodies (aPL). Despite the adoption of aPL titers in the …
Classification criteria for the antiphospholipid syndrome: not the same as diagnostic criteria for antiphospholipid syndrome
The latest consensus “guidelines” outlining revised Classification Criteria for
antiphospholipid syndrome (APS) has just been published. 1 The aim of this publication was …
antiphospholipid syndrome (APS) has just been published. 1 The aim of this publication was …
Atrial arrhythmia in adults with sickle cell anemia: a missing link toward understanding and preventing strokes
T d'Humières, Z Sadraoui, L Savale, L Boyer… - Blood …, 2024 - ashpublications.org
Although patients with homozygous sickle cell anemia (SCA) carry both significant left atrial
(LA) remodeling and an increased risk of stroke, the prevalence of atrial arrhythmia (AA) has …
(LA) remodeling and an increased risk of stroke, the prevalence of atrial arrhythmia (AA) has …
Dilemmas in the diagnosis and management of antiphospholipid syndrome
JE Manning, DJ Arachchillage - Journal of Thrombosis and Haemostasis, 2024 - Elsevier
Antiphospholipid syndrome (APS) is characterized by thrombosis (which may be venous,
arterial, or microvascular) and/or pregnancy morbidity in association with persistently …
arterial, or microvascular) and/or pregnancy morbidity in association with persistently …